Commensal intestinal microbiota (Gut microbiota)

The commensal intestinal microbiota is a complex and dynamic ecosystem comprising trillions of microorganisms, including bacteria, archaea, fungi, and viruses, that reside in the human gastrointestinal tract (NIH, 2023). It plays a fundamental role in host health by facilitating the digestion of complex carbohydrates, synthesizing essential vitamins such as K and B12, and providing a critical defense against enteric pathogens through competitive exclusion (Nature Reviews Microbiology, 2022). Beyond local digestion, the microbiota is a key regulator of the systemic immune system and metabolic homeostasis, influencing the development of lymphoid tissues and the production of signaling metabolites like short-chain fatty acids (PubMed, 2021). Dysbiosis, or the pathological imbalance of these microbial communities, is strongly associated with diseases such as Clostridioides difficile infection, inflammatory bowel disease (IBD), and metabolic syndrome (Mayo Clinic, 2023). Therapeutic targeting of the microbiota has evolved from broad-spectrum antibiotics to precision interventions, including fecal microbiota transplantation (FMT) and defined microbial consortia like Rebyota and Vowst, which aim to restore ecological stability and host-microbe symbiosis (FDA, 2023).

Other names

Gut microbiotaIntestinal floraGut microbiomeGastrointestinal microbiotaCommensal bacteria

Restoration of microbial diversity, competitive exclusion of pathogens, modulation of host-microbe metabolic signaling, and enhancement of intestinal barrier function (FDA, 2023; Nature Reviews Microbiology, 2022).